Compare GSK Consumer with KAVERI SEED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs KAVERI SEED - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER KAVERI SEED GSK CONSUMER/
KAVERI SEED
 
P/E (TTM) x 36.6 14.6 251.3% View Chart
P/BV x 10.8 3.4 320.9% View Chart
Dividend Yield % 0.8 0.6 138.1%  

Financials

 GSK CONSUMER   KAVERI SEED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
KAVERI SEED
Mar-18
GSK CONSUMER/
KAVERI SEED
5-Yr Chart
Click to enlarge
High Rs6,793704 964.9%   
Low Rs4,919468 1,052.1%   
Sales per share (Unadj.) Rs1,026.3124.0 827.9%  
Earnings per share (Unadj.) Rs166.532.0 520.4%  
Cash flow per share (Unadj.) Rs181.835.8 507.9%  
Dividends per share (Unadj.) Rs75.003.00 2,500.0%  
Dividend yield (eoy) %1.30.5 250.1%  
Book value per share (Unadj.) Rs828.6153.2 540.9%  
Shares outstanding (eoy) m42.0666.09 63.6%   
Bonus/Rights/Conversions -B-  
Price / Sales ratio x5.74.7 120.7%   
Avg P/E ratio x35.218.3 192.1%  
P/CF ratio (eoy) x32.216.4 196.8%  
Price / Book Value ratio x7.13.8 184.8%  
Dividend payout %45.19.4 480.4%   
Avg Mkt Cap Rs m246,28438,712 636.2%   
No. of employees `0004.00.9 451.1%   
Total wages/salary Rs m5,277544 970.3%   
Avg. sales/employee Rs Th10,837.39,277.8 116.8%   
Avg. wages/employee Rs Th1,325.0616.0 215.1%   
Avg. net profit/employee Rs Th1,757.72,394.2 73.4%   
INCOME DATA
Net Sales Rs m43,1658,192 526.9%  
Other income Rs m2,574237 1,087.5%   
Total revenues Rs m45,7398,429 542.6%   
Gross profit Rs m8,8342,218 398.2%  
Depreciation Rs m644251 256.7%   
Interest Rs m206 338.3%   
Profit before tax Rs m10,7442,198 488.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,74384 4,455.5%   
Profit after tax Rs m7,0012,114 331.2%  
Gross profit margin %20.527.1 75.6%  
Effective tax rate %34.83.8 911.6%   
Net profit margin %16.225.8 62.9%  
BALANCE SHEET DATA
Current assets Rs m45,62011,824 385.8%   
Current liabilities Rs m17,4264,199 415.0%   
Net working cap to sales %65.393.1 70.2%  
Current ratio x2.62.8 93.0%  
Inventory Days Days35197 17.5%  
Debtors Days Days2438 61.6%  
Net fixed assets Rs m5,1382,234 230.0%   
Share capital Rs m421132 318.2%   
"Free" reserves Rs m34,4319,992 344.6%   
Net worth Rs m34,85110,124 344.2%   
Long term debt Rs m029 0.0%   
Total assets Rs m54,12714,487 373.6%  
Interest coverage x530.2367.4 144.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.6 141.0%   
Return on assets %13.014.6 88.6%  
Return on equity %20.120.9 96.2%  
Return on capital %30.921.7 142.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,014131 2,303.7%   
Fx outflow Rs m18614 1,324.5%   
Net fx Rs m2,828117 2,421.2%   
CASH FLOW
From Operations Rs m7,2301,508 479.5%  
From Investments Rs m-4,465683 -653.4%  
From Financial Activity Rs m-3,634-2,262 160.7%  
Net Cashflow Rs m-868-71 1,227.9%  

Share Holding

Indian Promoters % 0.0 57.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 9.3 8.6%  
FIIs % 12.0 18.9 63.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 14.1 105.0%  
Shareholders   26,457 12,876 205.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   TILAKNAGAR IND.  GOODRICKE  ITC  TATA COFFEE  GODFREY PHILLIPS  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

KAVERI SEED Announces Quarterly Results (1QFY20); Net Profit Up 9.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, KAVERI SEED has posted a net profit of Rs 2 bn (up 9.3% YoY). Sales on the other hand came in at Rs 6 bn (up 7.9% YoY). Read on for a complete analysis of KAVERI SEED's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

KAVERI SEED Announces Quarterly Results (4QFY19); Net Profit Up 37.7% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, KAVERI SEED has posted a net profit of Rs 114 m (up 37.7% YoY). Sales on the other hand came in at Rs 447 m (up 7.5% YoY). Read on for a complete analysis of KAVERI SEED's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Feb 18, 2019 | Updated on Feb 18, 2019

For the quarter ended December 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 35.1% YoY). Sales on the other hand came in at Rs 11 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Oct 18, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - REI AGRO LTD. COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS